ABSTRACI'. Bilirubin toxicity produces significant neurologic and audiologic sequelae. Successful therapeutic intervention requires an understanding of the timing of neural dysfunction after exposure to bilirubin. BAEP were used in an animal model of bilirubin encephalopathy to study the onset of neural dysfunction after acute injection of a sulfonamide used to displace bilirubin out of the bloodstream and into tissue. Fourteen pairs of jaundiced Gunn rats from eight litters were studied at postnatal day 18. Baseline BAEP recordings were performed in anesthetized animals; then either sulfadimethoxine or an equal volume of saline was injected into the peritoneum. Another BAEP was done immediately, and then 2, 4, and 8 h after injection. Human serum albumin was injected into an additional 10 animals after the 2-h BAEP recording to see if induced BAEP abnormalities could be corrected. The sulfonamide-treated jj rats developed increased latencies for waves I1 and 111, and 1-11 and 1-111 interwave intervals ( p < 0.0001). The latencies were prolonged by 2 h after injection and became progressively longer at 4 and 8 h. The amplitudes of waves I1 and I11 progressively decreased at 2, 4, and 8 h ( p < 0.0001). Latency and amplitude of waves I and IV did not change. The rats injected with albumin at 2 h showed improvement of BAEP abnormalities at 8 h. These studies show that neurophysiologic abnormalities occur as early as 2 h after intraperitoneal injection of sulfadimethoxine, and are reversible with appropriate therapy. These abnormalities are hypothesized to be due to the sulfonamide driven net transfer of free, toxic bilirubin into the central nervous system. The rapid development of these BAEP abnormalities provides a model system in which the timing and efficacy of therapeutic intervention may be evaluated. (Pediatr Res 23: 306-310,1988) ' Presented in part at the 15th Annual Meeting of the Child Neurology Society, October 9, 1986, Boston, MA.
Bilirubin toxicity produces significant neurologic and audiologic sequelae. Successful therapeutic intervention to prevent such sequelae requires understanding the onset of neural dysfunction after exposure to bilirubin. To better understand the pathogenesis of bilirubin toxicity in the central nervous system we studied acute bilirubin encephalopathy produced by giving an albumin-binding sulfonamide, sulfadimethoxine, to immature jj Gunn rats.
The jj Gunn rat (I), a mutant of the Wistar strain, has an autosomal recessive trait and lacks hepatic ducuronvl transferase activity (2) , which converts unconjugated to conjugated bilirubin jaundiced Gunn rats have chronic. life-long hmerbilirubinemia -<.
which attains peak concentration h the 3rd wk of postnatal life (3, 4) . Their neuropathologic abnormalities include damage to central auditory structures, especially the cochlear nuclei and inferior colliculi (5, 6) .
The neuropathologic abnormalities are greatly accentuated by giving albumin-binding drugs such as sulfonamide. Sulfonamides displace bilirubin from serum albumin (7); free bilirubin enters brain tissue (8) and produces a pathologic syndrome that closely resembles human kernicterus (3, 4, (9) (10) (11) (12) (13) . This technique has been widely used in the jj Gunn rat to study the pathogenesis of bilirubin encephalopathy (4, 9, 10) .
To document functional abnormalities in acute bilirubin encephalopathy, BAEP were studied in infant jj rats after injecting sulfadimethoxine. After obtaining BAEP abnormalities, human serum albumin was given to decrease brain bilirubin concentration (8) in an attempt to reverse these abnormalities.
MATERIALS AND METHODS
The recording of BAEP in Gunn rats has been described previously (14) . Briefly, animals were anesthetized with ip injection of ketamine (40 mg/kg) and acepromazine (4 mg/kg); smaller supplemental doses were given as needed. Temperature, measured continuously with a deep rectal probe, was maintained at 37.0-37.2" C with a heating pad and a servo-controlled lamp for 10 min before and during BAEP recordings. Subcutaneous platinum electrodes were inserted at the vertex and at the right and left mastoids. Scalp electrical activity was amplified lo5 (Nicolet HGA-200A), filtered from 30 to 3000 Hz (Nicolet NIC-50 1A) and averaged (Nicolet 1 170) for 10.24 ms poststimulus. The stimuli were 100 ps clicks (Grass S88D) at 75 dB SPL delivered at 33.5 clicks/s by a Sony Walkman 4LIS speaker placed over the right external canal just touching the pinna. All recordings were done in a sound attenuated animal chamber (I.A.C. AC-3). Each BAEP, consisting of the averaged response to 2048 clicks, was replicated and plotted separately; for data analysis the two replicated BAEP were added and cursored digitally according to objective criteria (1 5).
To assure that sulfadimethoxine injection had the intended This timing was chosen after preliminary studies established that significant BAEP abnormalities appeared within 15 to 45 min and continued for several more hours after ip sulfadimethoxine injection ( Fig. 1) . Experiment 2. To establish the potential for reversibility of induced BAEP abnormalities, an additional 10 jj were given sulfadimethoxine 100 mg/kg initially plus human albumin (2 g/ kg, ip) 2 h later. Matched littermate controls were given either saline alone or sulfadimethoxine 100 mg/kg, as in the first experiment.
The latencies and amplitudes of waves I, 11, 111, and IV were chosen by objective criteria (15) . In experiment 1 the dependent variables of wave I latency, amplitudes of waves I, 11, 111 , and IV, and the derived measures of the I-II, 1-111, I-IV, and 11-111 IWI (first wave minus second wave; e.g. the I-II interwave interval equals wave I1 latency minus wave I latency) were examined. In experiment 2 only the measures shown to be of greatest interest in experiment 1 and previous experiments in jj Gunn rats were analyzed: the I-II IWI, and the amplitudes of waves I1 and 111 (14, 15) .
Statistical analyses were done by mixed design, repeated measures ANOVA (BMDP4V, BMDP Statistical Software). Post hoc trend analyses and two-tailed t intervals (with correction for unequal variance) were used to show differences between groups. RESULTS BAEP changes in infant jj rats may appear as early as 15 injection of sulfadimethoxine (Fig. 1) . Sulfadimethoxine injection has no effect on the BAEP of Jj rats (Fig. 1) .
Total plasma bilirubin and the molar radio of bilirubin to albumin decrease in jj rats 4 h after sulfadimethoxine 100 mg/ kg ip (Table 1) . Hematofluorometer analyses of total blood bilirubin, albumin bound bilirubin, and saturation index (17) (18) (19) (20) showed similar results, although this methodology has not been validated in rats.
Experiment I. In the experimental protocol, both groups of jj rats show the expected four BAEP waves pre-and immediately postinjection (Fig. 2) . BAEP abnormalities in the sulfonamideinjected jj rats are present in the 2-h recordings and worsen at 4 and 8 h compared to the noninjected control group's BAEP, and and over a baseline of 1.9 1 + 0.1 1 ms at 2, 4, and 8 h in the sulfonamide-injected group. However, the increased I-II IWI accounts for most of the increase in 1-111. Only at 2 h does the 11-111 IWI contribute independently to the 1-111 increase (Fig. 4) . The larger variability of 11-111 in the experimental group at 4 and 8 h is due in part to the difficulty of choosing wave I11 latency in some animals with abnormal BAEP because wave I11 amplitude is so small. The amplitudes and latencies of waves I and IV, and the I-IV IWI are unaffected after sulfonamide injection. BAEP latencies, IWI, and amplitudes in the saline-injected control rats are initially no different from the sulfadimethoxine-injected group and do not change during the course of the experiment. Experiment 2. The spontaneous recovery of the BAEP abnormalities in some sulfadimethoxine-injected jj rats suggests that reversal of neurophysiologic dysfunction is possible. In newborn animals injected with bilirubin, infusion of human serum albumin removes bilirubin previously deposited in brain tissue (8) . Human serum albumin, 2 g/kg, was injected into the peritoneum of 10 jj rats 2 h after sulfadimethoxine injection.
A partial reversal of the sulfadimethoxine-induced I-II IWI abnormality appears 4 h after the initial sulfadimethoxine injec- Fig. 7 . Reversibility of sulfa-induced I-II IWI abnormality with intraperitoneal albumin. In the sulfa plus albumin group ( n = lo), albumin 2 mg/kg ip was injected after the 2-h BAEP recording. The sulfa ( n = 23) and saline (n = 19) comparison groups include animals from experiment 1. Note the partial reversal of the abnormal I-II latency beginning at 4 h that becomes statistically significant at 8 h. differential recordings both are followed by the largest negative trough of the BAEP, and both frequently appear as a smaller wave or plateau riding on the negative deflection of the previous wave (14) . Therefore, the increased I-II and 1-111 IWI herein correspond to the increased 1-111 and I-V IWI in hyperbilirubinemic human newborns, and the decreased amplitudes of I1 and I11 in rats correspond to the decreased amplitudes of I11 and V in humans (24) (25) (26) .
The specific changes of Gunn rat BAEP waves suggest the anatomical localization of auditory dysfunction. The I-II IWI and the wave I1 amplitude abnormalities localize dysfunction to the level of the cochlear nuclei in the brainstem. Abundant histologic evidence in Gunn rats and humans indicates that the cochlear nuclei are extensively damaged by bilirubin (5, 6, 32) . Wave I11 amplitude and latency abnormalities in this study indicate either dysfunction of the ascending auditory pathways rostra1 to the cochlear nuclei and/or abnormal input from the cochlear nuclei to these pathways. Substituting human waves I11 and V for rat waves I1 and 111, the same reasoning amlies to the ---tion, i.e, after albumin (Fig. 7) . At 8 the I-II IWI is localization of human auditory dysfunction with BAEP. significantly less than the sulfonamide-injected group not given Wave IV, unaffected in this and previous studies of jaundiced albumin (p = 0.0002 by one-tailed t test).
rats (14, 1 9 , does not appear to be a sensitive indicator of centtal The sulfonamide-induced loss of amplitude of waves II and 111 auditory abnormalities in acute bilirubin encephalopathy. With is not reversed by albumin by the time ofthe 4-or 8-h recordings. serial activation of waves, if waves I1 and I11 are altered then However, a continued loss of wave I1 amplitude between 4 and wave IV be too. The wave IV with 8 h in the untreated group is prevented by albumin.
abnormal waves I1 and I11 suggests that wave IV in the rat may be generated by a pathway parallel to that which generates waves DISCUSSION The technique of sulfonamide injection in the jj Gunn rat is used to produce histologic abnormalities that are very similar to kernicterus in hyperbilirubinemic human neonates (3, 9-1 3). It has been argued that the acute bilirubin encephalopathy produced by sulfonamide augmentation mimics human disease better than the chronic bilirubin encephalopathy of jj rats not given sulfonamide (10) . Findings in the Gunn rat given sulfonamide have in the past had direct impact on clinical practice (21) . The Gunn rat model was chosen because of the considerable information already accumulated, and its clinical, biochemical, and histologic similarities to the human disease state (3, 4, 9) . The similarity of Gunn rat BAEP abnormalities to those that occur in hyperbilirubinemic humans (14, 15, 22) further supports this as a good model for studying the neurophysiologic effects of bilirubin encephalopathy. The failure of bilirubin infusion alone to produce BAEP changes in adult normal rats (23) argues against this as a good model, inasmuch as BAEP changes do occur in human bilirubin encephalopathy (24) (25) (26) .
Results of this study in infant Gunn rats confirm the blood biochemical alterations expected of the sulfonamide injection, namely a lowering of bilirubin and the molar ratio of bilirubin to albumin in the circulation. These are consistent with previous biochemical studies in adult Gunn rats (3, 9, 10, 27) , and support the notion that the sulfonamide acts to promote the net transfer of bilirubin out of the circulation and into tissue such as the central nervous system (3, (7) (8) (9) 28) .
To our knowledge, this is the first study of BAEP in the Gunn rat/sulfonamide model. The acute BAEP abnormalities induced herein are dramatic. Previous studies have found increased I-II IWI and decreased amplitudes of I1 and I11 in jaundiced adult (14, 22) and infant (1 5) Gunn rats. The findings with sulfonamide injection are similar but more severe.
Hyperbilirubinemic human newborns have BAEP abnormalities similar to those in Gunn rats. However, the anatomical localization of the generators of BAEP waves in rats is different than in humans. In humans, wave I1 arises from the proximal portion of the auditory nerve, outside the brainstem (29) , while in rats it is most likely generated in the brainstem cochlear nucleus (30, 3 1) . Wave I11 in rats has some of the electrophysiologic characteristics of wave V in humans: in vertex to mastoid I1 and 111.
The absence of wave I latency and amplitude changes in acute bilirubin encephalopathy suggests that the peripheral auditory system (inner ear and eighth nerve) is not the primary site of auditory pathology in acute bilirubin encephalopathy. This is consistent with morphologic studies that have not demonstrated inner ear abnormalities in Gunn rats (22, 33) . However, the possibility that the absence of effect may be due to measurement insensitivity or error cannot be excluded for either wave I or IV.
The BAEP changes appear rapidly. Even though the sulfadimethoxine is injected ip and is a long-acting sulfonamide, abnormalities are often seen in this laboratory 15 min after injection of 100 mg/kg, and almost always by 60 min. This is consistent with the finding by Ahlfors et al. (34) of BAEP changes 12 min after a loading intravenous dose of sulfonamide in a premature monkey preinfused with bilirubin. The current study, however, does not focus in detail on BAEP changes occurring less than 2 h after sulfonamide injection. The time course of the earliest BAEP changes would be best studied after intravenous infusion of sulfonamide along with measurement of sulfonamide and bilirubin pharmacokinetics. It is expected that the timing of these early changes relates to 1) sulfadimethoxine dose, route of administration, and absorption rate, 2) the entry rate of bilirubin into the central nervous system, 3) the initial bilirubin concentration, and 4) the availability of bilirubin and sulfadimethoxine binding sites in the circulation.
The BAEP abnormalities are not due to the sulfonamide itself because Jj rats injected with sulfonamide do not develop BAEP abnormalities, and sulfonamide alone does not produce histopathology in Jj rats (9, 10) . The experimental procedures, including anesthesia, are not responsible for the abnormalities because the jaundiced control rats are unaffected.
To our knowledge, this study presents the first evidence of the reversibility of auditory dysfunction due to bilirubin toxicity in a prospectively controlled experiment. Recent studies have shown reversibility of BAEP abnormalities in hyperbilirubinemic human neonates after exchange transfusion (35, 36) and in a premature infant rhesus monkey after albumin after being infused with bilirubin and administered sulfisoxazole (34) .
We hypothesize that the neurophysiologic abnormalities occurring earlier than 2 h after intraperitoneal injection of sulfadimethoxine are due to the sulfonamide-driven net transfer of free, toxic bilirubin into the central nervous system, the mechanism SHAPIRO for sulfonamide-induced bilirubin encephalopathy proposed by Odell (7) . Measures that promote the net transfer of bilirubin from brain tissue, such as the early administration of human serum albumin, improve neurophysiologic function and may prevent permanent neurologic sequelae.
Brainstem auditory evoked potentials add new dimension to the study of the Gunn rat model of bilirubin encephalopathy. Because BAEP are noninvasive and may be obtained continuously, they may be used to study the time of onset, age dependency, and the reversibility of neurophysiologic dysfunction. The rapid development of these BAEP abnormalities provides a model system in which the timing of therapeutic intervention may be evaluated. In the present study, administration of human serum albumin 2 h after sulfa injection produces a partial reversal of the neurophysiologic dysfunction. Whether reversibility is possible by intervention after longer durations of abnormalities remains to be determined, as do the biochemical and histologic correlates of these functional findings. These experiments dealing with BAEP reversibility in Gunn rats may encourage the development of clinical studies. By using BAEP criteria in addition to clinical and biochemical data, it may be possible to establish better guidelines for the treatment of hyperbilirubinemic neonates.
